Diversion must be minimized, and that has to be a priority. I am not opposed to pharmaceutical-grade opioids being prescribed, but is it appropriate to be prescribing short-acting opioids? No. I've already stated that it is counterproductive. Giving take-home doses prematurely when a patient is not stable in their recovery—they've not engaged in their psychotherapy counselling—is not appropriate. For someone who is actively suffering from addiction to be given these short-acting opioids is just something that will deter them from engaging in lifestyle changes.
There must be some approach that encourages engagement with the patient and the therapist. The purpose of the opioid replacement therapy is to avoid the patient going into withdrawal or suffering from overwhelming cravings. Once those symptoms are eradicated, the patient is stable and more likely to be able to engage in the psychotherapeutic medium that is provided.